Inflammatory disease not major risk factors for severe COVID-19, focus on comorbidities urged

FHS
May 3, 2024
10:30 am

Severe coronavirus disease 2019 (COVID-19) outcomes in patients with immune-mediated inflammatory diseases (IMIDs).

The biotech scoreboard for the second quarter: 32 stock-moving events to watch

Here is STAT’s biotech scoreboard, our regular ledger of stock-moving biotech events, for the second quarter and middle of the year: Obesity catalysts, first. advertisement

April 2, 2024

Gradient Health Acquires DataAppraisal to Expand Medical AI

What You Should Know: – Gradient Health, a leading provider of medical imaging data for AI development, has acquired DataAppraisal, a healthcare AI company specializing

October 25, 2024

Vanqua raises $45M; Aerovate to look for strategic alternatives

Plus, news about GSK, iTeos, Oxolife and SmallCella: Vanqua Bio reels in $45M: The Chicago neuroscience biotech extended its Series B, a spokesperson confirmed to

July 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.